XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.23.1

Business segment information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Segment Reporting [Abstract] |
Summary of EBITDA by Reporting Segment | The table below presents adjusted EBITDA by reporting segment:
|  | Three Months Ended March 31, |
(Unaudited, U.S. Dollars, in thousands) |  |  | 2023 |  |  | 2022 |
Adjusted EBITDA by reporting segment |  |  |  |  |  |  |
Global Spine |  |  |  | 14,981 |  |  |  | 14,033 |
Global Orthopedics |  |  |  | 44 |  |  |  | (804 | )
Corporate |  |  |  | (11,821 | ) |  |  | (6,120 | )
Consolidated adjusted EBITDA |  |  | $ | 3,204 |  |  | $ | 7,109 |
Reconciling items: |  |  |  |  |  |  |
Interest expense, net |  |  |  | 1,289 |  |  |  | 375 |
Depreciation and amortization |  |  |  | 12,670 |  |  |  | 7,516 |
Share-based compensation expense |  |  |  | 13,020 |  |  |  | 4,332 |
Foreign exchange impact |  |  |  | (583 | ) |  |  | 1,242 |
SeaSpine merger-related costs |  |  |  | 20,740 |  |  |  | — |
Strategic investments |  |  |  | 661 |  |  |  | 970 |
Acquisition-related fair value adjustments |  |  |  | 11,636 |  |  |  | (5,500 | )
Legal judgments/settlements |  |  |  | 469 |  |  |  | 193 |
Medical device regulation |  |  |  | 3,629 |  |  |  | 1,952 |
Business interruption - COVID-19 |  |  |  | — |  |  |  | 343 |
All other |  |  |  | — |  |  |  | 75 |
Loss before income taxes |  |  | $ | (60,327 | ) |  | $ | (4,389 | )
Summary of Net Sales by Geographic Destination for each Reporting Segment | The table below presents net sales by geographic destination for each reporting segment and for the consolidated Company:
|  | Three Months Ended March 31, |
(Unaudited, U.S. Dollars, in thousands) |  | 2023 |  |  | 2022 |
Global Spine |  |  |  |  |  |
U.S. |  | $ | 139,457 |  |  | $ | 77,066 |
International |  |  | 9,749 |  |  |  | 5,589 |
Total Global Spine |  |  | 149,206 |  |  |  | 82,655 |
Global Orthopedics |  |  |  |  |  |
U.S. |  |  | 6,636 |  |  |  | 5,327 |
International |  |  | 19,362 |  |  |  | 18,436 |
Total Global Orthopedics |  |  | 25,998 |  |  |  | 23,763 |
Consolidated |  |  |  |  |  |
U.S. |  |  | 146,093 |  |  |  | 82,393 |
International |  |  | 29,111 |  |  |  | 24,025 |
Net sales |  | $ | 175,204 |  |  | $ | 106,418 |

X
- Definition Schedule of earnings before interest, taxes, depreciation and amortization. + References No definition available. + Details
Name: | ofix_ScheduleOfEarningsBeforeInterestTaxesDepreciationAndAmortizationTableTextBlock
Namespace Prefix: | ofix_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph a -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration